(Chairman of the Advisory Board)
Mr. Zhao is the Chief Executive Officer of CMBI and Chief Investment Officer of CMB. He has led CMBI to become one of the most
renowned one-stop financial institutions in Hong Kong.

Dr. Zhou is a member of the executive committee of CMBI and the general manager of CMBISZ. He has deep investment and industry expertise in the life science sector.

Mr. Yu is a Managing Director of CMBI and a key member of the investment committee of CMBI SZ. He has a strong track record of
private equity investments in the green energy sector.

(Chief Executive Officer and Chairman of the Board)

Mr. Jiang is a Managing Director at CMBI and the general manager of CMBI’s asset management department and a key member of CMBI’s investment committee, responsible for CMBI’s China offshore alternative investment business which includes private equity investment.

(Chief Financial Officer)
Dr. Zhang is a Managing Director at CMBI. He has more than 10 years of extensive working experience in private equity investment across consumption, enterprise services, TMT, energy and high-end manufacturing sectors. He served as investment committee member of multiple funds held under CMBI.

(Chief Operating Officer and Executive Director)
Ms. Le is a Vice President at CMBI. She is responsible for project investments of CMBI’s offshore funds. She has led the execution
of multiple transactions primarily in the new economy sectors in China, such as investments in JD Logistics, Inc. (HK: 02618),
Xiaomi Corporation (HK: 01810) and Tencent Music Entertainment Group (NYSE: TME). She has worked closely with CMBI’s
healthcare team and participated in transactions in the biotech sector and has also led multiple Southeast Asia deals with a China
angle.

Ms. Wu is a Managing Director at CMBI. She is responsible for product and sales of CMBI AM, and supervises the overall
operations and post-investment management of CMBI’s offshore investments. She has expertise in deal structuring, including
cross border transactions and transactions financing.

Ms. Qi is a Managing Director at CMBI. She focuses on private equity investments in the technology field, especially fintech. Her investment track record includes investments in Credo Technology (SH) Ltd., Chengdu Kelai Network Technology Co., Ltd. and Beijing Tongxinshang Technology Development Co., Ltd.

Mr. Zhong is the founding managing partner of M31 Capital and was a senior managing director and global partner at Fosun
International Limited (HK: 656).

Dr. Gong was the Chairman of J.P. Morgan China Investment Banking and Chairman of J.P.Morgan China Diversified Industry
Clients from 2009 to 2015 until his retirement.

Mr. Ng is the former national head of technology and media sectors for KPMG in China. Mr. Ng is a Member of American Institute
of Certified Public Accountants and a Chartered Global Management Accountant.